Comparative Pharmacology
Head-to-head clinical analysis: CROTAN versus NATROBA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CROTAN versus NATROBA.
CROTAN vs NATROBA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Crotan (crotamiton) is a scabicide and antipruritic agent with unknown exact mechanism. It is thought to act against Sarcoptes scabiei by disrupting nervous system function, possibly via sodium channel modulation, and provides symptomatic relief of pruritus through local anesthetic-like effects.
Natroba is a pediculicide that inhibits neuronal depolarization by binding to and blocking voltage-gated sodium channels in the nervous system of lice, leading to paralysis and death of the parasite.
Croton oil is not used therapeutically; crotamiton is used as a scabicide. Typical adult dose: Apply 10% cream or lotion topically to entire body from neck to toes, leave on for 24 hours, then wash off; repeat once after 7 days.
Apply a single, 10-minute application of the lotion (0.5% w/w ivermectin) to dry hair and scalp in an amount sufficient to thoroughly coat the hair and scalp (up to 1 tube for adults); rinse off with water after 10 minutes.
None Documented
None Documented
Terminal elimination half-life is 4-6 hours in patients with normal renal function; prolonged to 12-24 hours in severe renal impairment, necessitating dose adjustment.
Terminal elimination half-life is approximately 10–12 hours in patients with normal hepatic function; prolonged in severe hepatic impairment.
Primarily renal excretion of unchanged drug (approx. 60-70%) with biliary/fecal elimination accounting for 20-30%; less than 10% excreted as metabolites.
Primarily fecal (approximately 90% of absorbed dose) with minor renal elimination (<10% as unchanged drug).
Category C
Category C
Antiparasitic
Antiparasitic, Topical